LACOSAMIDE for Relapsing-remitting multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 6 adverse event reports in the FDA FAERS database where LACOSAMIDE was used for Relapsing-remitting multiple sclerosis.
Most Reported Side Effects for LACOSAMIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Seizure | 4,585 | 21.6% | 197 | 1,763 |
| Drug ineffective | 2,945 | 13.9% | 237 | 1,102 |
| Off label use | 2,811 | 13.3% | 296 | 1,037 |
| Dizziness | 974 | 4.6% | 10 | 257 |
| Overdose | 971 | 4.6% | 72 | 376 |
| Generalised tonic-clonic seizure | 918 | 4.3% | 29 | 314 |
| Epilepsy | 902 | 4.3% | 52 | 306 |
| Status epilepticus | 874 | 4.1% | 129 | 491 |
| Fall | 780 | 3.7% | 42 | 418 |
| Somnolence | 768 | 3.6% | 27 | 273 |
| Multiple-drug resistance | 739 | 3.5% | 83 | 155 |
| Fatigue | 698 | 3.3% | 16 | 206 |
| Death | 679 | 3.2% | 679 | 78 |
| Maternal exposure during pregnancy | 627 | 3.0% | 18 | 74 |
| Headache | 561 | 2.6% | 6 | 166 |
Other Indications for LACOSAMIDE
Epilepsy (5,941)
Seizure (5,700)
Product used for unknown indication (4,678)
Partial seizures (1,479)
Status epilepticus (1,445)
Off label use (842)
Generalised tonic-clonic seizure (495)
Focal dyscognitive seizures (259)
Partial seizures with secondary generalisation (172)
Temporal lobe epilepsy (142)
Other Drugs Used for Relapsing-remitting multiple sclerosis
OCRELIZUMAB (15,658)
FINGOLIMOD (8,814)
OFATUMUMAB (3,864)
DIMETHYL (3,638)
NATALIZUMAB (2,749)
INTERFERON BETA-1A (2,058)
GLATIRAMER (1,965)
ALEMTUZUMAB (1,604)
TERIFLUNOMIDE (1,320)
RITUXIMAB (956)